GALAPAGOS NV's ticker is GLPG and the CUSIP is 36315X101. A total of 70 filers reported holding GALAPAGOS NV in Q3 2017. The put-call ratio across all filers is 1.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $41,000 | -99.1% | 410 | -98.7% | 0.00% | -99.2% |
| Q3 2020 | $4,505,000 | -34.5% | 31,743 | -8.9% | 0.12% | -39.0% |
| Q2 2020 | $6,877,000 | -12.2% | 34,859 | -12.8% | 0.20% | -30.6% |
| Q1 2020 | $7,833,000 | -40.3% | 39,983 | -37.0% | 0.28% | -15.9% |
| Q4 2019 | $13,122,000 | +20.3% | 63,444 | -11.2% | 0.33% | +12.5% |
| Q3 2019 | $10,906,000 | +11.1% | 71,442 | -6.2% | 0.30% | +22.7% |
| Q2 2019 | $9,818,000 | -1.8% | 76,148 | -10.3% | 0.24% | -3.2% |
| Q1 2019 | $10,000,000 | +25.8% | 84,900 | -2.0% | 0.25% | +11.6% |
| Q4 2018 | $7,950,000 | -18.9% | 86,658 | -0.7% | 0.22% | -3.4% |
| Q3 2018 | $9,807,000 | -1.2% | 87,227 | -19.0% | 0.23% | -6.5% |
| Q2 2018 | $9,925,000 | -2.6% | 107,675 | +5.4% | 0.25% | -0.4% |
| Q1 2018 | $10,189,000 | -7.3% | 102,136 | -12.9% | 0.25% | -3.5% |
| Q4 2017 | $10,990,000 | +1.3% | 117,211 | +10.0% | 0.26% | -0.8% |
| Q3 2017 | $10,846,000 | +23.9% | 106,594 | -6.8% | 0.26% | +19.3% |
| Q2 2017 | $8,754,000 | -11.4% | 114,399 | -0.6% | 0.22% | -13.1% |
| Q1 2017 | $9,878,000 | +15.0% | 115,049 | -14.0% | 0.25% | +12.6% |
| Q4 2016 | $8,589,000 | – | 133,813 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 250,680 | $13,188,000 | 7.26% |
| Stonepine Capital Management, LLC | 244,205 | $12,848,000 | 5.85% |
| Sio Capital Management, LLC | 224,719 | $11,822,000 | 3.77% |
| EcoR1 Capital, LLC | 1,558,749 | $82,006,000 | 2.85% |
| BVF INC/IL | 1,119,733 | $58,909,000 | 2.30% |
| 683 Capital Management, LLC | 701,421 | $36,902,000 | 1.44% |
| DAFNA Capital Management LLC | 77,675 | $4,086,000 | 1.08% |
| Soleus Capital Management, L.P. | 115,300 | $6,066,000 | 0.94% |
| APOGEM CAPITAL LLC | 19,267 | $1,014,000 | 0.64% |
| Orbimed Advisors | 723,457 | $38,061,000 | 0.42% |